By Jim Stafford Copyright © 2018, The Oklahoma Publishing Co. BOSTON — Craig Shimasaki, Ph.D., commanded the attention of an audience of biotech investors and industry onlookers here Tuesday as he pitched the potential of Oklahoma City’s Moleculera Labs. Shimasaki, co-founder and CEO of Moleculera Labs, made his presentation as one of about 50 up-and-comingRead more
Copyright © 2017, The Oklahoma Publishing Co. Oklahoma City’s Moleculera Labs Inc., an autoimmune neurobiology company, said Monday that a key patent has been issued covering the company’s method of identifying whether someone’s neurologic or psychiatric symptoms could be caused by an autoimmune dysfunction. The patent covers Moleculera’s methods of diagnosing pediatric acute-onset neuropsychiatric syndromeRead more
By Jim Stafford Copyright © 2017, The Oklahoma Publishing Co. In his second book, “Biotechnology Entrepreneurship: Starting, Managing and Leading Biotech Companies,” Craig Shimasaki, Ph.D., titles one section “Learning from Failure.” “Failure is not a person or way of life; failure is an event,” Shimasaki said. “Interestingly, you learn immeasurably more from things that don’tRead more
For OU graduate student Amanda Curtis, the 2016 BIO show required some unique multi-tasking skills. Curtis greeted visitors to the Oklahoma exhibition booth, participated in Oklahoma Bioscience networking events and sat in on multiple partnering meetings with her colleagues from OU’s Office of Technology Development. All in a day’s work.
Increasing evidence points to a relationship between certain bacterial infections and autoimmune attacks that can disrupt normal neurologic functioning, according to researchers at Moleculera Labs. Using a panel of biomarker tests for autoantibodies against specific neuronal antigens and a key enzyme involved in the upregulation of many neurotransmitters can help physicians better diagnose and treat the underlying cause of such conditions, which are often misdiagnosed as psychiatric illnesses, motor tics or autism spectrum disorders and treated inappropriately with psychotropic drugs.
By Journal Record Staff Copyright © 2015 The Journal Record OKLAHOMA CITY – Moleculera Labs Inc. has received renewal of Commission on Office Laboratories Accreditation certification. The company’s testing services are licensed in 49 states, with licensure in New York state pending. The Moleculera tests, known collectively as the Cunningham Panel, help physicians determine whether theRead more
